Inventor
Albert B. Deisseroth
Inventor
Potomac, MD, US
Overview
Patents· 30 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes27%
C12NMicroorganisms or enzymes25%
C07KPeptides24%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations16%
C12YEnzymes3%
Y02ATechnologies for adaptation to climate change3%
C07CAcyclic or carbocyclic compounds1%
C07DHeterocyclic compounds1%
PatentTitleYear
11,097,001Composition and method against tuberculosis202111,077,183CD40 ligand fusion protein vaccine202111,027,006Adenoviral vector vaccine202110,835,589Vaccine directed to induction of immune response to protein and glycolipid antigens of bacterial cells through interaction of CD40L/CD40 receptor axis with complex of glycolipid/CD1d receptor in NKT cells and in dendritic cells202010,426,827Dengue hemorrhagic fever virus vaccine201910,383,932Vaccine directed to induction of immune response to protein and glycolipid antigens of bacterial cells through interaction of CD4OL/CD40 receptor axis with complex of glycolipid/CD1d receptor in NKT cells and in dendritic cells201910,293,040Pharmaceutical compositions and methods of blocking 201910,183,067TAA/CD4OL composition/vaccine for malaria201910,174,100Multivalent DNA composition for 201910,166,284Vaccines for herpes simplex virus 1 and 2201910,149,899Composition and method against C-difficile201810,130,667TAA/ecdCD40L oncolytic virus201810,046,041Methods and compositions for suppressing virulence of methicillin resistant 20189,889,188'Ebola virus composition/vaccine'20189,757,438'Mucin antigen vaccine'20179,642,901'TAA/CD40L vaccine for malaria'20179,533,036'Methods for generating immune responses to influenza antigens with a secretable CD40L fusion protein'20179,526,774'Methods and compositions for suppressing virulence of methicillin resistant Staphylococcus aureus '20169,458,221'Adenoviral expression vector encoding a CD40L fusion protein'20169,402,920'Mucin antigen vaccine'20169,353,167'Methods for generating immunity to antigen'20168,828,957'Methods for generating immunity to antigen'20148,742,087'Mucin antigen vaccine'20148,540,979'Methods of generating immune responses with compositions comprising an adenoviral expression vector comprising a CD40L fusion protein'20138,501,707'Mucin antigen vaccine'20138,299,229'Mucin antigen vaccine'20128,236,295'Composition comprising an adenoviral expression vector comprising a CD40L fusion protein for generating immune responses'20128,119,117'Adenoviral expression vector comprising a CD40L fusion protein adapted to elicit cellular immunity'20127,304,092'Compounds and methods for treating tumors, cancer and hyperproliferative diseases'20075,417,978'Liposomal antisense methyl phosphonate oligonucleotides and methods for their preparation and use'1995Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1995Based in Houston, TX, US· patent location history
2007–2017Based in San Diego, CA, US· patent location history
2012–2021Patents assigned to MICROVAX LLC (23)· patent assignee history
2012–2020Patents assigned to DEISSEROTH ALBERT B (8)· patent assignee history
2012–2021Patents assigned to VAXUM LLC (5)· patent assignee history
2012–2017Patents assigned to DEISSEROTH ALBERT (3)· patent assignee history
2012–2017Patents assigned to TANG YUCHENG (3)· patent assignee history
2012–2021Based in Potomac, MD, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| MICROVAX LLC | 23 | 2012–2021 |
| DEISSEROTH ALBERT Bself | 8 | 2012–2020 |
| VAXUM LLC | 5 | 2012–2021 |
| DEISSEROTH ALBERTself | 3 | 2012–2017 |
| TANG YUCHENG | 3 | 2012–2017 |
Locations
| Location | Patents | Span |
|---|---|---|
| Potomac, Maryland, US | 24 | 2012–2021 |
| San Diego, California, US | 5 | 2007–2017 |
| Houston, Texas, US | 1 | 1995 |